Mike Hollan

The games are designed to promote activities that exercise the brain.

Marcel Botha discusses whether AI can truly be used to replace laid off human workers at FDA.

Chandler previously held leadership positions at Cencora and CVS Health.

The majority of respondents not already enrolled in the program have concerns that the program won’t survive until the point when they need it.

Marcel Botha discusses ways the agency can ensure it gets the most accurate results possible from AI.

The agency stated that the letters were made public to promote transparency.

The new doll will include an insulin pump, a glucose monitor, and a dress featuring international symbols for diabetes awareness.

Ohtuvayre will become part of Merck’s cardio-pulmonary pipeline.

Marcel Botha discusses what the technology is most effective at in the FDA approval process.

Justin Kozak discusses how the impact on medical breakthroughs and startups.

The organization says that millions of Americans will lose access to mental health care.

The delivery method showed promise in preventing the illness.

Between tariffs, funding cuts, and changes at HHS, pharma is facing new challenges.

The AI company’s tech will be integrated with Microsoft Azure’s infrastructure.

The fundraising event will debut in Nashville this August.

The football player is speaking out about his experience living with and treating OAB.

Olympia Pharmaceuticals’ co-founders discuss how they’re pivoting in light of FDA’s decision.

Jeff Liter, CEO of Luminary, discusses his company’s approach to CAR-T therapies and why the developing Saudi market has potential.

Customers will be able to access prescription services through the NovoCare Pharmacy.

The actor suffers from the ear condition after an accident on set during the filming of Star Trek.

People on both Medicaid and Medicare struggle navigating both services.

New rules places upon the pharma industry will have a significant impact on how investors view the industry.

The results show many people start dropping the medication by the first year of using it.

Williams will serve as entrepreneur-in-chief and will help groups in the program with mentorship.

New technologies and external factors are forcing companies to rethink financial planning and analysis.

The drug-maker cited concerns over deceptive marketing and the selling of compounded GLP-1 medications.

This is the latest partnership for PharmaJet.

Members will have access to oncology specialists.

Jim Weiss, founder and chairman of Real Chemistry, and the 2025 HBA Honorable Mentor, discusses the foundation and journey behind his lifelong advocacy for mentorship—and, cliché or not, the lasting power of “you get what you give.”

The study is part of a larger movement analyzing the health habits of people taking these medications.